Zimmer Biomet Holdings (ZBH) Interest & Investment Income (2009 - 2018)
Zimmer Biomet Holdings' (ZBH) quarterly Interest & Investment Income came in at $800000.0 in Q3 2018, up 33.33% year-on-year from $600000.0 in Q3 2017, and up 33.33% quarter-over-quarter from $600000.0 in Q2 2018.
Zimmer Biomet Holdings (ZBH) Interest & Investment Income (2009 - 2018) Analysis & Trends
Zimmer Biomet Holdings' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $800000.0 for Q3 2018.
- On a quarterly basis, Interest & Investment Income rose 33.33% year-over-year to $800000.0 in Q3 2018; TTM through Sep 2018 was $3.1 million, a 93.75% increase from a year earlier, with the FY2019 full-year figure at $2.8 million, changed N/A from the prior year.
- Interest & Investment Income grew to $800000.0 in Q3 2018 per ZBH's latest filing, from $600000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.5 million in Q4 2014 and bottomed at $200000.0 in Q4 2016.
- The 5-year median for Interest & Investment Income is $900000.0 (2018), against an average of $1.5 million.
- Across the five-year window, Interest & Investment Income plunged 90.0% in 2016 and soared 300.0% in 2017, its largest moves.
- Year by year, Interest & Investment Income stood at $3.5 million in 2014, then tumbled by 42.86% to $2.0 million in 2015, then plunged by 90.0% to $200000.0 in 2016, then surged by 300.0% to $800000.0 in 2017, then changed by 0.0% to $800000.0 in 2018.
- Per Business Quant, the three latest ZBH Interest & Investment Income figures stand at $800000.0 (Q3 2018), $600000.0 (Q2 2018), and $900000.0 (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Zimmer Biomet Holdings | 17.99 Bn | 17.57 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 800,000.00 |
| Jun 30, 2018 | 600,000.00 |
| Mar 31, 2018 | 900,000.00 |
| Dec 31, 2017 | 800,000.00 |
| Sep 30, 2017 | 600,000.00 |
| Jun 30, 2017 | 300,000.00 |
| Mar 31, 2017 | 500,000.00 |
| Dec 31, 2016 | 200,000.00 |
| Sep 30, 2016 | 600,000.00 |
| Jun 30, 2016 | 800,000.00 |
| Mar 31, 2016 | 1.30 Mn |
| Dec 31, 2015 | 2.00 Mn |
| Sep 30, 2015 | 2.30 Mn |
| Jun 30, 2015 | 2.50 Mn |
| Mar 31, 2015 | 2.60 Mn |
| Dec 31, 2014 | 3.50 Mn |
| Sep 30, 2014 | 3.00 Mn |
| Jun 30, 2014 | 2.90 Mn |
| Mar 31, 2014 | 2.50 Mn |
| Dec 31, 2013 | 4.20 Mn |